Propranolol-induced seizures in mice: The role of noradrenaline

Cellular and Molecular Life Sciences

Volumn 53, Issue 8, 1997, Pages 646-651

  Amabeoku, G J ^a   Syce, J A ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Mice; Noradrenergic mechanism; Propranolol; Seizures

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; DIAZEPAM; DISULFIRAM; IDAZOXAN; IMIPRAMINE; ISOPRENALINE; METIROSINE; NORADRENALIN; PARGYLINE; PHENOBARBITAL; PHENYLEPHRINE; PHENYTOIN; PRAZOSIN; PROPRANOLOL; RESERPINE; THREO 3,4 DIHYDROXYPHENYLSERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SEIZURE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC UPTAKE INHIBITORS; ALPHA-METHYLTYROSINE; ANIMALS; DISULFIRAM; DROXIDOPA; DRUG SYNERGISM; FEMALE; IMIPRAMINE; ISOPROTERENOL; MALE; MICE; NOREPINEPHRINE; PARGYLINE; PROPRANOLOL; RESERPINE; SEIZURES;

ANIMALIA;

EID: 0030703171     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050083     Document Type: Article

References (28)

1. Forster R. W. (1996) Noradrenergic neurotransmission as a target of drug action. In: Basic Pharmacology, 4th ed., pp. 76-102, Forster R. W. (ed.), Butterworth Heineman, Oxford
2. Rang H. P., Dale M. M. and Ritter J. M. (1995) Noradrenergic transmission. In: Pharmacology, 3rd ed., pp. 148-167. Rang H. P., Dale M. M. and Ritter J. M. (eds). Churchill Livingstone, Edinburgh
3. Louis W. J., Papanicolaou J., Summers R. J. and Vajda F. J. (1982) Role of central β-adrenoceptors in the control of pentylenetetrazol-induced convulsions in rats. Br. J. Pharmacol. 75: 441-446
4. Madan B. R. and Barar F. S. (1974) Anticonvulsant activity of some β-adrenoceptor blocking agents in mice. Eur. J. Pharmacol. 29: 1-4
5. Yeah P. N. and Wolf H. H. (1968) Effects of some adrenergic agents on low frequency electroshock seizures. J. Pharmaceat. Sci. 57: 340-342
6. Weinstein R. S. (1984) Recognition and management of poisoning with β-adrenergic blocking agents. Ann. Emerg. Med. 13: 1123-1131
7. Frishman W. H., Jacob H., Eisenberg F. S. and Spivack C. R. (1984) Overdosage with β-adrenoceptor blocking drugs; pharmacological considerations and clinical management. In: Clinical Pharmacology of β-Adrenoceptor Blocking Drugs, pp. 169-203. Frishman W. H. (ed.), Appleton-Century-Crofts, Norwalk
8. Ivnan R. E., Fisher M. M. and Ibels L. S. (1981) Self-poisoning with propranolol. Med. J. Aust. 1: 82-83
9. Buiumsohn A., Eisenberg F. S., Jacob H., Rosen N. and Bock J. (1979) Seizures and intraventricular conduction defect in propranolol poisoning. Ann. Int. Med. 91: 860-862
10. Dadkar V. N., Dahanuker S. A. and Sheth U. K. (1979) Role of dopaminergic and noradrenergic mechanisms in metrazol convulsions in mice. Indian J. Med. Res. 70: 492-494
11. Amabeoku G. J. (1993) The involvement of noradrenaline, 5-hydroxytryptamine and acetylcholine in imipramine-induced seizures in mice. Experientia 49: 859-864
12. Jobe P. C. and Laird H. F. (1987) Neurotransmitter systems and the epilepsy models: distinguishing features and unifying principles. In: Neurotransmitters and Epilepsy. pp. 339-366. Jobe P. C. and Laird H. E. (eds), Humana Press, Clifton
13. Kobayashi K. and Mori A. (1977) Brain monoamines in seizure mechanism. Folia Psychiat. Neurol. Japonica 31: 483-489
14. Maj J., Grabowska M. and Gajda F. (1972) Effect of apomorphine on motility in rats. Eur. J. Pharmacol. 17: 798-811
15. Vellucci S. V. and Webster R. A. (1984) Antagonism of caffeine-induced seizures in mice by Ro 15-1788. Eur. J. Pharmacol. 97: 289-293
16. Papanicolaou J., Summers R. J., Vajda F. J. and Louis W. J. (1982) Anticonvulsant effects of clonidine mediated through central alpha-2 adrenoceptors. Eur. J. Pharmacol. 77: 163-166
17. 2-adrenoceptor antagonists. Br. J. Pharmacol. 81: 39P
18. Blaschko H., Burn J. H. and Langeman H. J. (1950) Formation of noradrenaline from dihydroxyphenylserine. J. Pharmacol. Chemother. 5: 431-437
19. Thorn G. D. and Ludwig R. A. (1962) The Diethylthiocarbamates and Related Compounds, pp. 298-301. Elsevier. Amsterdam
20. Forster R. W. (1996) Antidepressant drugs. In: Basic Pharmacology, 4th ed., pp. 232-236. Forster R. W. (ed.), Butterworth Heineman, Oxford
21. Chermat R., Doare L., Lachapelle F. and Simon F. (1981) Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse. Naunyn-Schmiedebergs Arch. Pharmacol. 318: 94-99
22. De Schaepdryver A. F., Piette Y. and Delaunoise A. L. (1962) Brain amines and electroshock threshold. Arch. Int. Pharmacodyn. Ther. 140: 358-367
23. Lehmann A. (1967) Audiogenic seizures data in mice supporting new theories of biogenic amines mechanism in the central nervous system. Life Sci. 13: 1423-1431
24. Spector S., Sjoerdsma R. and Udenfried S. (1965) Blockade of endogenous norepinephrine synthesis by x-methyl-p-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Expl Ther. 147: 86-95
25. Svensson T. and Waldech B. (1970) On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase. Psychopharmacologia 18: 357-360
26. Kruk Z. L. and Pycock C. J. (1979) Noradrenergic transmission. In: Neurotransmitters and Drugs, pp. 40-62, Croom and Helm, London
27. Rang H. P., Dale M. M. and Ritter J. M. (1995) Antiepileptic drugs and centrally acting muscle relaxants. In: Pharmacology, 3rd ed., pp. 596-608, Rang H. P., Dale M. M. and Ritter J. M. (eds), Churchill Livingstone, Edinburgh
28. Frishman W. H., Jacob H., Eisenberg E. and Ribner H. (1979) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. self-poisoning with β adrenergic blocking agents: recognition and management. Am. Heart J. 98: 798-811